RE:RE:Yesterday's Press ReleaseThe other issue is that new and better ARTs have been developed and tweaking the ART regime has been all it takes to keep viral loads down. Maybe at some point years down the road, the tweaking for a patient has only gone so far and they may add in Trogarzo. But viral loads are being controlled other ways. And now you have Rukobia and Biktarvy advertising on TV that they do that. Hard to compete with that.
palinc2000 wrote: The biggest issue with Trogarzo is not how it is administered but still IV Push makes it an improvement for those on Trogarzo,
The biggest issue is messaging and lack of understanding by physicians of the added benefits of controlling viral loads ,,,So the increased sales will come from providing physicians with more info on the benefits and Paul and his team are spending a lot of time in trying to be more convincing